Advertisement

Advertisement

2022 Community Oncology Alliance Annual Meeting

Multiple Myeloma

By Caroline Helwick / June 10, 2022 / 2022 Community Oncology Alliance Annual Meeting

Multiple Myeloma: Treatment Conundrums

The availability of numerous new agents for treating multiple myeloma has created some “conundrums” for clinicians, said Sergio Giralt, MD, Deputy Head of the Division of Hematologic Malignancies at M...

Issues in Oncology

By Chase Doyle / May 25, 2022 / 2022 Community Oncology Alliance Annual Meeting

The Future of Community Oncology Practice

Although community oncology practice may have been changing before the COVID-19 pandemic, it amplified industry trends. At the 2022 Community Oncology Alliance’s Community Oncology Conference, a panel...

Advertisement

Advertisement

Jul

01

Today In Oncology

Study Finds About One in Six Chemotherapy Drugs in Sub-Saharan Africa Fails Quality Tests

Partial-Breast Radiotherapy After Breast-Conserving Surgery: 10-Year Outcomes

Neoadjuvant Durvalumab Plus Chemotherapy for High-Risk Upper Tract Urothelial Carcinoma

Patterns of ICI Use and Survival Outcomes in Metastatic Colorectal Cancer

Genitourinary Oncology Highlights: Treatment Advances in Renal Cell, Bladder, Urothelial, and Prostate Cancers

Advertisement

© 2025 HSP News Service, L.L.C.